Tuberculosis: Our Impact

 {Photo credit: MSH staff}Pharmacists at KIU Teaching Hospital view data in the Pharmaceutical Information PortalPhoto credit: MSH staff

Until 2012, Uganda’s public health supply chain was uncoordinated because the information needed to estimate quantities of essential medicines and health supplies was not readily available. A national centralized platform to track routine monitoring of stock levels, share information to support data-driven decisions, and provide accountability of funds and commodities did not exist. Without knowledge of stock levels, funding could not be properly allocated to procure needed commodities.

 {Photo credit: MSH staff}A district TB and leprosy supervisor conducts supportive supervision.Photo credit: MSH staff

According to the National population based TB prevalence survey, each year, 87,000 Ugandans develop tuberculosis (TB), a preventable and curable disease. Strides have been made to notify more cases. In 2019, the National TB and Leprosy program notified 61,372 cases, leading to a 76% (61,372/80,412) treatment success rate. This was a huge improvement, with a 53% treatment success rate reported three years earlier.Many patients go untreated due to poor health-seeking behavior and limited access to health services.

{Photo Credit: Warren Zelman}Photo Credit: Warren Zelman

By Berhanemeskal Assefa Woldemariam, Principal Technical Advisor, Management Sciences for HealthAs a country with high rates of tuberculosis (TB), Ethiopia is working to expand services and improve TB case finding.

Unable to work, Rasel worried about how his family would survive while he went through treatment for drug-resistant TB.Photo credit: Challenge TB Bangladesh

Bangladesh is a global hotspot for TB, and the country’s government and its partners are hard at work to find and treat missing cases of TB and prevent the spread of multidrug-resistant TB (MDR-TB). The available treatment for MDR-TB is expensive, lengthy, and complex, and the disease is often considered a death sentence.

One of the first patients in Bangladesh to receive the shorter treatment regimen, Billal survived multi-drug resistant TB and returned to his life and his family.Photo credit: Challenge TB Bangladesh

Living with TB is very hard, and living with drug-resistant TB (DR-TB) is even worse. The drugs needed to treat DR-TB are not only toxic but also very expensive, and treatment can take as long as two years to complete. In April 2017, with the support of USAID’s Challenge TB (CTB) project, Bangladesh started its first patients on a shorter treatment regimen for DR-TB.

Left to right: Dr. Daniel Gemechu, Regional Director for CTB/Ethiopia , Dr. Ahmed Bedru, Country Director for CTB/Ethiopia , Mr. Taye Letta, National TB Program Manager, Dr. Liya Tadesse, State Minister of Health, Dr. Kitty van Weezenbeek, Executive Director of KNCV and Dr. Pedro Suarez, Senior Director, Infectious Disease Cluster at MSH.

At last week’s end of project ceremony, the USAID-funded Challenge TB project celebrated improvements in Ethiopia’s ability to save lives by detecting, diagnosing, and treating TB more effectively.Under this five-year program, USAID invested $42 million to improve the quality of TB care and prevention services, enabling patients to receive better access to treatment and medication to fight the disease. TB deaths have dropped significantly as treatment success rates rose above 90%, with 75% of those suffering from multidrug-resistant TB now able to beat the disease after comple

{Photo credit: Warren Zelman}Photo credit: Warren Zelman

What is the purpose of the USAID-funded Medicines, Technologies, and Pharmaceuticals Services (MTaPS) program, and what will the program accomplish?MTaPS recently published a collection of brief publications that provide information on the program’s objectives and planned activities.

Tuberculosis remains the world’s leading infectious disease killer, claiming 4,500 lives each day. Every year, some 558,000 people will develop a form of TB that is resistant to rifampicin, the most effective first-line drug, making successful treatment of the disease even more difficult and costly. Ending the global epidemic requires a comprehensive approach, rapid innovation and proven interventions, bold leadership, and intensive community engagement.

This story was originally published on systemone.id. SystemOne LLC, (Springfield, MA), Management Sciences for Health (MSH) (Medford, MA) and the Tableau Foundation (Seattle, WA) recently concluded the first Data Fellowship Program for TB staff from the National TB programs and Ministries of Health. Eight participants from five participating countries attended the week-long training session in Johannesburg, using their own country’s GxAlert diagnostic data to uncover ways to improve healthcare delivery and patient impact.

 {Photo Credit: Rhiana Smith}Aziz Abdallah, DHSS Project Director, MSH, greets guests at end-of-project eventPhoto Credit: Rhiana Smith

The District Health System Strengthening and Quality Improvement for Service Delivery (DHSS) Project shared its achievements on Wednesday, March 7, after five years of work to reduce the burden of HIV/AIDS in Malawi. Guests gathered at the Bingu International Conference Center in Malawi’s capital, Lilongwe, for an end-of-project event that featured speakers from DHSS, the Ministry of Health, United States Centers for Disease Control and Prevention (CDC), and Management Sciences for Health (MSH), which led the DHSS Project,  

Pages